Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Disease

Bursa Yüksek İhtisas Education and Research Hospital

Status: Completed

Conditions: Behcet's Disease; Central Sensitisation

Treatments: Other: Sleep disturbance; Diagnostic Test: Neuropathic pain; Other: Quality of life; Diagnostic Test: Central sensitisation

Study type: Observational

Funder types: Other

Identifiers

NCT03531385

2011-KAEK-25 2018/03-12

Details and patient eligibility

About

There are few studies in the literature regarding increased frequency of neuropathic pain and sleep disturbance and decreased quality of life in Behçet's disease. Frequency of central sensitization was not investigated in patients with Behçet's disease before. In this study, it is aimed to investigate the frequency of central sensitization, neuropathic pain, sleep disorder and quality of life and their relation to each other in Behcet's disease.

Full description

Central sensitization reduces the pain threshold in the pain pathways of the nervous system, causing pain sensation to be perceived with lower stimuli and often causing chronic pain. Central sensitization can be seen with many conditions such as neuropathic pain and sleep disorders, as well as with inflammatory diseases such as rheumatoid arthritis. There are few studies in the literature regarding increased frequency of neuropathic pain and sleep disturbance and decreased quality of life in Behçet's disease. Frequency of central sensitization was not investigated in patients with Behçet's disease before. In this study, it is aimed to investigate the frequency of central sensitization, neuropathic pain, sleep disorder and quality of life and their relation to each other in patients with Behcet's disease and healthy controls.

Enrollment: 200 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients diagnosed with Behcet disease according to international study group criteria
• Healthy volunteers without previously known systemic chronic disease
• Patients older than 18
• Patients younger than 75

Exclusion criteria

• Participants which were previously diagnosed with diabetes mellitus
• Participants which were previously diagnosed with chronic renal failure
• Pregnant women

Trial design

200 participants in 2 patient groups

Behcet

Description:

Patients diagnosed with Behcet disease

Treatment:

Diagnostic Test: Neuropathic pain

Other: Sleep disturbance

Other: Quality of life

Diagnostic Test: Central sensitisation

Healthy controls

Description:

Individuals without any chronic disease

Treatment:

Diagnostic Test: Neuropathic pain

Other: Sleep disturbance

Other: Quality of life

Diagnostic Test: Central sensitisation